Anika Therapeutics (ANIK) News Today $14.50 -0.36 (-2.39%) Closing price 03:59 PM EasternExtended Trading$14.50 0.00 (0.00%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Alta Fundamental Advisers LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK)Alta Fundamental Advisers LLC grew its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 136.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 700,432 shares of the biotechnology company's stock after buying an additional 404,350 shares duMay 5 at 7:43 AM | marketbeat.comAnika Therapeutics (ANIK) Projected to Post Quarterly Earnings on FridayAnika Therapeutics (NASDAQ:ANIK) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-anika-therapeutics-inc-stock/)May 4 at 1:35 AM | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Boothbay Fund Management LLCBoothbay Fund Management LLC lifted its holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 5.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 529,503 shares of the bApril 28, 2025 | marketbeat.comJPMorgan Chase & Co. Raises Position in Anika Therapeutics, Inc. (NASDAQ:ANIK)JPMorgan Chase & Co. raised its holdings in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 431.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,491 shares of the biotechnology company'sApril 28, 2025 | marketbeat.com21,367 Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK) Purchased by XTX Topco LtdXTX Topco Ltd purchased a new stake in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 21,367 shares of the biotechnology company's stock, valued at approximately $352,0April 26, 2025 | marketbeat.comHead to Head Contrast: Adynxx (OTCMKTS:ADYX) & Anika Therapeutics (NASDAQ:ANIK)April 26, 2025 | americanbankingnews.comAnika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025April 25, 2025 | globenewswire.comTrigran Investments Inc. Sells 102,682 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)Trigran Investments Inc. trimmed its holdings in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 4.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,021,778 shares of the biotechnology company'April 22, 2025 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Upgraded to Strong-Buy at B. RileyB. Riley raised shares of Anika Therapeutics to a "strong-buy" rating in a research report on Wednesday.April 20, 2025 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC trimmed its position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 8.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 528,517 shares of the biotechnology company's stock after selling 45,712 sApril 20, 2025 | marketbeat.comB. Riley Begins Coverage on Anika Therapeutics (NASDAQ:ANIK)B. Riley initiated coverage on shares of Anika Therapeutics in a research report on Thursday. They set a "buy" rating and a $21.00 price target for the company.April 19, 2025 | marketbeat.comAnika Therapeutics (ANIK) Receives 'Buy' Rating with $21 Target from B. ...April 17, 2025 | gurufocus.comAnika Therapeutics (ANIK) Receives 'Buy' Rating with $21 Target from B. ...April 17, 2025 | gurufocus.comArrowstreet Capital Limited Partnership Has $979,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK)Arrowstreet Capital Limited Partnership decreased its holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 45.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 59,455 shares of the biotechnologyApril 14, 2025 | marketbeat.comAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 7, 2025 | globenewswire.comAre Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock?April 3, 2025 | msn.comQ1 Earnings Forecast for ANIK Issued By Barrington ResearchAnika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) - Investment analysts at Barrington Research issued their Q1 2026 EPS estimates for Anika Therapeutics in a research note issued on Thursday, March 13th. Barrington Research analyst M. Petusky forecasts that the biotechnology company will earnMarch 17, 2025 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Upgraded to Buy at StockNews.comStockNews.com upgraded shares of Anika Therapeutics from a "hold" rating to a "buy" rating in a research note on Thursday.March 14, 2025 | marketbeat.comAnika Therapeutics Full Year 2024 Earnings: Misses ExpectationsMarch 14, 2025 | ca.finance.yahoo.comBarrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00Barrington Research cut their price target on Anika Therapeutics from $25.00 to $20.00 and set an "outperform" rating for the company in a research note on Thursday.March 14, 2025 | marketbeat.comQ4 2024 Anika Therapeutics Inc Earnings CallMarch 14, 2025 | finance.yahoo.comAnika Therapeutics price target lowered to $20 from $25 at BarringtonMarch 14, 2025 | markets.businessinsider.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | msn.comAnika Therapeutics (NASDAQ:ANIK) Issues Earnings ResultsAnika Therapeutics (NASDAQ:ANIK - Get Free Report) announced its earnings results on Wednesday. The biotechnology company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.13). Anika Therapeutics had a negative net margin of 59.40% and a negative return on equity of 2.22%.March 13, 2025 | marketbeat.comAnika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and ChallengesMarch 13, 2025 | gurufocus.comQ4 2024 Anika Therapeutics Inc Earnings Call TranscriptMarch 13, 2025 | gurufocus.comAnika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comAnika Therapeutics reports Q4 EPS (3c), consensus 9cMarch 12, 2025 | markets.businessinsider.comAnika Therapeutics, Inc. Reports 2024 Financial Results with 17% Growth in Commercial Channel Revenue and Key Strategic AdvancesMarch 12, 2025 | quiverquant.comAnika Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Purchased by Capital Management Corp VACapital Management Corp VA boosted its position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 12.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 325,545 shares of the biotechnology company's stockMarch 9, 2025 | marketbeat.comAnika Therapeutics Inc.: Anika Completes Divestiture of Parcus MedicalMarch 7, 2025 | finanznachrichten.deAnika Completes Divestiture of Parcus MedicalMarch 7, 2025 | globenewswire.comAnika Therapeutics (ANIK) Expected to Announce Quarterly Earnings on WednesdayAnika Therapeutics (NASDAQ:ANIK) will be releasing earnings after the market closes on Wednesday, March 12, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=670346)March 5, 2025 | marketbeat.comIs Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now?March 1, 2025 | insidermonkey.comAnika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025February 26, 2025 | globenewswire.comAnika To Present at the Canaccord Genuity 2025 Musculoskeletal ConferenceFebruary 25, 2025 | globenewswire.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lessened its stake in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 37.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,274 shares of the biFebruary 24, 2025 | marketbeat.comAnika To Participate in 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest UpdateAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 367,500 shares, a decline of 27.8% from the November 15th total of 508,900 shares. Based on an average daily volume of 92,800 shares, the days-to-cover ratio is currently 4.0 days. Currently, 2.6% of the shares of the stock are sold short.December 13, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Sees Significant Growth in Short InterestAnika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 508,900 shares, a growth of 5.1% from the October 31st total of 484,400 shares. Currently, 3.6% of the shares of the stock are sold short. Based on an average daily volume of 85,500 shares, the days-to-cover ratio is presently 6.0 days.December 3, 2024 | marketbeat.comAnika To Participate in December 2024 Investor ConferencesNovember 22, 2024 | globenewswire.comAnika Therapeutics Navigates Geopolitical Risks Amid Global ConflictsNovember 7, 2024 | markets.businessinsider.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VACapital Management Corp VA trimmed its position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 11.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 290,350 shares of thNovember 5, 2024 | marketbeat.comAnika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.comStockNews.com downgraded Anika Therapeutics from a "buy" rating to a "hold" rating in a research note on Monday.November 4, 2024 | marketbeat.comAnika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | msn.comAnika Therapeutics price target lowered to $25 from $37 at BarringtonNovember 3, 2024 | markets.businessinsider.comAnika (ANIK) Earnings Dates & ReportsNovember 3, 2024 | investing.comAnika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | seekingalpha.comAnika Therapeutics Third Quarter 2024 Earnings: Misses ExpectationsNovember 2, 2024 | finance.yahoo.com Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIK Media Mentions By Week ANIK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIK News Sentiment▼1.220.72▲Average Medical News Sentiment ANIK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIK Articles This Week▼22▲ANIK Articles Average Week Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cerus News OraSure Technologies News Utah Medical Products News Cooper Companies News West Pharmaceutical Services News Align Technology News Merit Medical Systems News ICU Medical News Haemonetics News DENTSPLY SIRONA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIK) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIK Stock Free ANIK Stock Alerts